PHUN vs REGN · rev $3.2M vs P/E 14, rev $14.34B
Phunware Inc (PHUN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Phunware Inc (PHUN) is a software - application company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PHUN revenue for 2024-12-31 was $3.2M. Net income was -$10.3M. Revenue was down 34.0% from 2023-12-31 to 2024-12-31. PHUN currently screens at market cap $69.4M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PHUN currently screens at market cap $69.4M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PHUN and REGN stock pages for the full models.
Not investment advice.